Holdings of Select Health Care Portfolio
Fidelity Select Portfolios · Original filing · Compare with another fund · Report an error
- Net assets
- 5.8B $ including 5.6B $ in equities, 97.2 %
- Positions
- 104 in 10 countries
- Top ten
- 38.6 % of net assets
- Filed on
- May 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 420,000 | 464.1M $ | 8.03 % |
| 2 | Danaher Corp | 2,180,000 | 398.2M $ | 6.89 % |
| 3 | Johnson & Johnson | 1,260,000 | 283.9M $ | 4.91 % |
| 4 | Thermo Fisher Scientific Inc | 508,000 | 250.2M $ | 4.33 % |
| 5 | UnitedHealth Group Inc | 530,000 | 201.6M $ | 3.49 % |
| 6 | ALNYLAM PHARMACEUTICALS INC | 460,000 | 138.9M $ | 2.40 % |
| 7 | Gilead Sciences Inc | 950,000 | 127.7M $ | 2.21 % |
| 8 | Boston Scientific Corp | 2,600,000 | 125.6M $ | 2.17 % |
| 9 | Ascendis Pharma A/S | 560,000 | 125.5M $ | 2.17 % |
| 10 | AbbVie Inc | 540,000 | 117.6M $ | 2.03 % |
| 11 | UCB SA | 400,000 | 117.4M $ | 2.03 % |
| 12 | Bio-Techne Corp | 1,900,000 | 98.2M $ | 1.70 % |
| 13 | Merck & Co Inc | 780,000 | 92.6M $ | 1.60 % |
| 14 | Argenx SE | 108,000 | 90.3M $ | 1.56 % |
| 15 | CVS Health Corp | 820,000 | 74.6M $ | 1.29 % |
| 16 | Nuvalent Inc | 670,000 | 74M $ | 1.28 % |
| 17 | NATERA INC | 328,000 | 73.3M $ | 1.27 % |
| 18 | BRIGHTSPRING HEALTH SERVICES INC | 1,150,000 | 70.9M $ | 1.23 % |
| 19 | VIATRIS INC | 4,280,000 | 69.6M $ | 1.20 % |
| 20 | MODERNA INC | 1,450,000 | 68.4M $ | 1.18 % |
| 21 | Cencora Inc | 245,000 | 66M $ | 1.14 % |
| 22 | West Pharmaceutical Services Inc | 200,000 | 64.6M $ | 1.12 % |
| 23 | Agilent Technologies Inc | 470,800 | 63.8M $ | 1.10 % |
| 24 | Edwards Lifesciences Corp | 728,000 | 63M $ | 1.09 % |
| 25 | Xenon Pharmaceuticals Inc | 1,150,000 | 62.9M $ | 1.09 % |
| 26 | CARIS LIFE SCIENCES INC | 3,750,000 | 62.7M $ | 1.08 % |
| 27 | ROYALTY PHARMA PLC | 1,120,000 | 62.5M $ | 1.08 % |
| 28 | COGENT BIOSCIENCES INC | 1,750,000 | 61.2M $ | 1.06 % |
| 29 | GUARDANT HEALTH INC | 460,000 | 59.7M $ | 1.03 % |
| 30 | VAXCYTE INC | 1,160,000 | 59.6M $ | 1.03 % |
| 31 | Veracyte Inc | 1,280,000 | 59.3M $ | 1.03 % |
| 32 | Repligen Corp | 460,000 | 57M $ | 0.99 % |
| 33 | Spyre Therapeutics Inc | 760,000 | 55.9M $ | 0.97 % |
| 34 | JAZZ PHARMACEUTICALS PLC | 235,000 | 55.6M $ | 0.96 % |
| 35 | REVOLUTION MEDICINES INC | 350,000 | 55.1M $ | 0.95 % |
| 36 | LEGEND BIOTECH CORP | 2,000,000 | 54.3M $ | 0.94 % |
| 37 | Roche Holding AG | 128,000 | 54M $ | 0.93 % |
| 38 | PRIVIA HEALTH GROUP INC | 2,500,000 | 53.8M $ | 0.93 % |
| 39 | Insmed Inc | 500,000 | 53.5M $ | 0.92 % |
| 40 | Bruker Corp | 850,000 | 50.1M $ | 0.87 % |
| 41 | ORUKA THERAPEUTICS INC | 833,100 | 48.8M $ | 0.84 % |
| 42 | 10X Genomics Inc | 1,600,000 | 45.3M $ | 0.78 % |
| 43 | Axsome Therapeutics Inc | 190,000 | 44.6M $ | 0.77 % |
| 44 | Enliven Therapeutics Inc | 1,120,000 | 44.3M $ | 0.77 % |
| 45 | Elevance Health Inc | 110,000 | 43.3M $ | 0.75 % |
| 46 | Crinetics Pharmaceuticals Inc | 1,200,000 | 42.7M $ | 0.74 % |
| 47 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 844,907 | 40.9M $ | 0.71 % |
| 48 | ALIGNMENT HEALTHCARE INC | 2,600,000 | 39.8M $ | 0.69 % |
| 49 | LIFESTANCE HEALTH GROUP INC | 4,979,400 | 38.4M $ | 0.66 % |
| 50 | Roivant Sciences Ltd | 1,280,000 | 38.4M $ | 0.66 % |
| 51 | Mineralys Therapeutics Inc | 1,180,000 | 37.2M $ | 0.64 % |
| 52 | KYMERA THERAPEUTICS INC | 450,000 | 36.6M $ | 0.63 % |
| 53 | Medline Inc | 1,000,000 | 36.6M $ | 0.63 % |
| 54 | Praxis Precision Medicines Inc | 100,000 | 35M $ | 0.61 % |
| 55 | Intuitive Surgical Inc | 75,000 | 31.8M $ | 0.55 % |
| 56 | Disc Medicine Inc | 450,000 | 31.3M $ | 0.54 % |
| 57 | CG ONCOLOGY INC | 500,000 | 31.1M $ | 0.54 % |
| 58 | HeartFlow Inc | 1,000,000 | 31M $ | 0.54 % |
| 59 | Biogen Inc | 150,000 | 29.4M $ | 0.51 % |
| 60 | TRAVERE THERAPEUTICS INC | 570,000 | 26.9M $ | 0.47 % |
| 61 | Sartorius Stedim Biotech | 128,000 | 26.6M $ | 0.46 % |
| 62 | VIRIDIAN THERAPEUTICS INC | 1,500,000 | 26.4M $ | 0.46 % |
| 63 | BEONE MEDICINES LTD | 90,000 | 25.9M $ | 0.45 % |
| 64 | Pharvaris NV | 800,000 | 24.1M $ | 0.42 % |
| 65 | Relay Therapeutics Inc | 1,680,000 | 23.6M $ | 0.41 % |
| 66 | NEWAMSTERDAM PHARMA COMPANY NV | 690,000 | 23.2M $ | 0.40 % |
| 67 | MIRUM PHARMACEUTICALS INC | 220,000 | 22.3M $ | 0.39 % |
| 68 | WAYSTAR HOLDING CORP | 1,080,000 | 21.5M $ | 0.37 % |
| 69 | STRUCTURE THERAPEUTICS INC | 540,000 | 21.2M $ | 0.37 % |
| 70 | Scholar Rock Holding Corp | 430,000 | 21.2M $ | 0.37 % |
| 71 | IRhythm Holdings Inc | 180,000 | 20.5M $ | 0.35 % |
| 72 | AMYLYX PHARMACEUTICALS INC | 1,420,000 | 20.4M $ | 0.35 % |
| 73 | ZENAS BIOPHARMA INC | 1,080,000 | 19.9M $ | 0.34 % |
| 74 | Olema Pharmaceuticals Inc | 1,500,000 | 19.8M $ | 0.34 % |
| 75 | Stoke Therapeutics Inc | 628,000 | 19.4M $ | 0.34 % |
| 76 | Dianthus Therapeutics Inc | 207,448 | 19.3M $ | 0.33 % |
| 77 | Kestra Medical Technologies Ltd | 900,000 | 19.1M $ | 0.33 % |
| 78 | MBX BIOSCIENCES INC | 600,000 | 18.9M $ | 0.33 % |
| 79 | VERADERMICS INC | 180,000 | 18.2M $ | 0.31 % |
| 80 | CYTOMX THERAPEUTICS INC | 5,000,000 | 18M $ | 0.31 % |
| 81 | Viking Therapeutics Inc | 540,000 | 17.7M $ | 0.31 % |
| 82 | Insulet Corp | 100,000 | 14.5M $ | 0.25 % |
| 83 | Immunocore Holdings PLC | 500,000 | 14.4M $ | 0.25 % |
| 84 | Trevi Therapeutics Inc | 1,000,000 | 14.1M $ | 0.24 % |
| 85 | Summit Therapeutics Inc | 800,000 | 14M $ | 0.24 % |
| 86 | JADE BIOSCIENCES INC | 640,000 | 13.5M $ | 0.23 % |
| 87 | DAMORA THERAPEUTICS INC | 500,000 | 12.4M $ | 0.22 % |
| 88 | GMR Solutions Inc | 993,539 | 12.4M $ | 0.21 % |
| 89 | Edgewise Therapeutics Inc | 294,000 | 10M $ | 0.17 % |
| 90 | TYRA BIOSCIENCES INC | 280,000 | 9.4M $ | 0.16 % |
| 91 | SHOULDER INNOVATIONS INC | 545,286 | 8M $ | 0.14 % |
| 92 | OUTSET MEDICAL INC | 1,520,000 | 7.4M $ | 0.13 % |
| 93 | Apogee Therapeutics Inc | 90,007 | 7.4M $ | 0.13 % |
| 94 | Upstream Bio Inc | 800,000 | 6.7M $ | 0.12 % |
| 95 | ALUMIS INC | 301,364 | 6.5M $ | 0.11 % |
| 96 | Annexon Inc | 1,200,000 | 6.5M $ | 0.11 % |
| 97 | First Tracks Biotherapeutics Inc | 400,000 | 6.4M $ | 0.11 % |
| 98 | Alamar Biosciences Inc | 300,000 | 6.1M $ | 0.11 % |
| 99 | Contineum Therapeutics Inc | 450,000 | 6.1M $ | 0.11 % |
| 100 | OCULAR THERAPEUTIX INC | 494,535 | 4.5M $ | 0.08 % |
Sector breakdown
- Health care 56.3 %
- Unattributed 43.7 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 96.5 %
- EUR 2.6 %
- CHF 1.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 87.7 %
- Netherlands 2.4 %
- Denmark 2.2 %
- Belgium 2.1 %
- Canada 1.1 %
- Bermuda 1.0 %
- Ireland 1.0 %
- Cayman Islands 1.0 %
- Switzerland 1.0 %
- France 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 92 | 4.9B $ | 87.70 % |
| 2 | Netherlands | 3 | 137.7M $ | 2.45 % |
| 3 | Denmark | 1 | 125.5M $ | 2.23 % |
| 4 | Belgium | 1 | 117.4M $ | 2.09 % |
| 5 | Canada | 1 | 62.9M $ | 1.12 % |
| 6 | Bermuda | 2 | 57.5M $ | 1.02 % |
| 7 | Ireland | 1 | 55.6M $ | 0.99 % |
| 8 | Cayman Islands | 1 | 54.3M $ | 0.97 % |
| 9 | Switzerland | 1 | 54M $ | 0.96 % |
| 10 | France | 1 | 26.6M $ | 0.47 % |
Cite this page
Titelia. "Holdings of Select Health Care Portfolio". https://titelia.com/en/funds/S000007466